Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

NCT02659475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: PHEN/TPM ER (Qsymia®)

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]